FDA Adverse Event Injury Summary report: N

TALENT STENT GRAFT WITH XCELERANT - HYDRO

MDR report key: 2153206 · Received June 23, 2011

Report

Report Number
2953200-2011-01194
Event Type
Injury
Date Received
June 23, 2011
Date of Event
May 25, 2011
Report Date
May 25, 2011
Manufacturer
MEDTRONIC CARDIOVASCULAR
Product Code
MIH
PMA / PMN Number
P070027
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). EVALUATION RESULTS: ENDOLEAK, CAUSE OF JUNCTIONAL TYPE III ENDOLEAK IS UNKNOWN. CONCLUSION: CAUSE OF JUNCTIONAL TYPE III ENDOLEAK IS UNKNOWN.

Description of Event or Problem · 1

A TALENT STENT GRAFT SYSTEM WAS IMPLANTED IN A PATIENT FOR THE ENDOVASCULAR TREATMENT OF ABDOMINAL AND COMMON ILIAC ARTERY ANEURYSMS APPROXIMATELY 2 YEARS AGO. ANEURYSM AND VESSEL MORPHOLOGY WERE NOT REPORTED. DURING THE IMPLANT PROCEDURE, A 14X24X90 TALENT ILIAC FLARED LIMB WAS USED IN CONJUNCTION WITH A 28X28X40 ANEURX CUFF (MFR REPORT# 2953200-2011-01195) TO SEAL IN THE RIGHT COMMON ILIAC ARTERY IN ORDER TO PRESERVE THE INTERNAL ILIAC ARTERY. IT WAS REPORTED THAT THE PATIENT PRESENTED APPROXIMATELY 1 MONTH AGO WITH A JUNCTIONAL TYPE III ENDOLEAK, AS THE ANEURX CUFF BECAME SEPARATED FROM THE TALENT ILIAC LIMB IN THE RIGHT COMMON ILIAC ARTERY. THE PHYSICIAN ELECTED TO IMPLANT TWO LIMBS FROM ANOTHER MANUFACTURER AND A STENT FROM ANOTHER MANUFACTURER, WHICH SUCCESSFULLY RESOLVED THE TYPE III ENDOLEAK; HOWEVER, A DISTAL TYPE I ENDOLEAK WAS EVIDENT. THE PHYSICIAN THEN IMPLANTED A STENT FROM ANOTHER MANUFACTURER TO TREAT THE TYPE I ENDOLEAK AND ENDED UP COVERING THE RIGHT INTERNAL ILIAC ARTERY. NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED, AND THE PATIENT IS FINE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TALENT STENT GRAFT WITH XCELERANT - HYDRO MIH MEDTRONIC CARDIOVASCULAR NA V00252717

Patients

Seq Age Sex Outcome Treatment
1 74 YR Required Intervention